Qian Zhao

Urinary retinol binding protein is a potential biomarker for renal function in primary systemic amyloidosis: A retrospective study

Feng Li, Yu-Mei Tang, Liping Wang, 2016, Leukemia & lymphoma.

Prognostic impact of hyperdiploidy in multiple myeloma patients with high-risk cytogenetics: a pilot study in China

Feng Li, Liping Wang, Qian Zhao, 2018, Journal of Cancer Research and Clinical Oncology.

Clinical Characteristics and Treatment Outcome of Chinese Patients With Systemic Amyloid Light-Chain Amyloidosis: A Retrospective Single-Center Analysis.

Feng Li, Liping Wang, Qian Zhao, 2016, Clinical lymphoma, myeloma & leukemia.

A randomized phase II, open-label and multicenter study of combination regimens of bortezomib at two doses by subcutaneous injection for newly diagnosed multiple myeloma patients

Bing Chen, Fusheng Yao, Jiahua Ding, 2019, Journal of Cancer Research and Clinical Oncology.

MB4-2/MB4-3 transcripts of IGH-MMSET fusion gene in t(4;14)pos multiple myeloma indicate poor prognosis.

J. Hou, Hui Zhang, Feng Li, 2017, Oncotarget.

Biomimetic codelivery overcomes osimertinib-resistant NSCLC and brain metastasis via macrophage-mediated innate immunity.

Yongzhuo Huang, Meng Zhang, Feng Li, 2020, Journal of controlled release : official journal of the Controlled Release Society.

Achieving minimal residual disease-negative by multiparameter flow cytometry may ameliorate a poor prognosis in MM patients with high-risk cytogenetics: a retrospective single-center analysis

Feng Li, Qian Zhao, Yongping Zhai, 2019, Annals of Hematology.

[Comparison analysis of outcomes in primary light chain amyloidosis patients treated by auto peripheral blood stem cell transplantation or bortezomib plus dexamethasone].

Feng Li, Liping Wang, Qian Zhao, 2016, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

Poor outcomes of immunoglobulin D multiple myeloma patients in the era of novel agents: a single-center experience

Feng Li, Qian Zhao, Yongping Zhai, 2019, Cancer communications.